These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 23188436)

  • 61. Telomere length alterations unique to invasive lobular carcinoma.
    Heaphy CM; Asch-Kendrick R; Argani P; Meeker AK; Cimino-Mathews A
    Hum Pathol; 2015 Aug; 46(8):1197-203. PubMed ID: 26092192
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Evaluation of HER2/neu oncoprotein in serum & tissue samples of women with breast cancer.
    Shukla S; Singh BK; Pathania OP; Jain M
    Indian J Med Res; 2016 May; 143(Supplement):S52-S58. PubMed ID: 27748278
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Tumor phenotype and breast density in distinct categories of interval cancer: results of population-based mammography screening in Spain.
    Domingo L; Salas D; Zubizarreta R; Baré M; Sarriugarte G; Barata T; Ibáñez J; Blanch J; Puig-Vives M; Fernández A; Castells X; Sala M;
    Breast Cancer Res; 2014 Jan; 16(1):R3. PubMed ID: 24410848
    [TBL] [Abstract][Full Text] [Related]  

  • 64. 18F-FDG PET of locally invasive breast cancer and association of estrogen receptor status with standardized uptake value: microarray and immunohistochemical analysis.
    Osborne JR; Port E; Gonen M; Doane A; Yeung H; Gerald W; Cook JB; Larson S
    J Nucl Med; 2010 Apr; 51(4):543-50. PubMed ID: 20237034
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mammographic features of triple receptor-negative primary breast cancers in young premenopausal women.
    Yang WT; Dryden M; Broglio K; Gilcrease M; Dawood S; Dempsey PJ; Valero V; Hortobagyi G; Atchley D; Arun B
    Breast Cancer Res Treat; 2008 Oct; 111(3):405-10. PubMed ID: 18026834
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Characteristics of breast cancers detected by ultrasound screening in women with negative mammograms.
    Bae MS; Han W; Koo HR; Cho N; Chang JM; Yi A; Park IA; Noh DY; Choi WS; Moon WK
    Cancer Sci; 2011 Oct; 102(10):1862-7. PubMed ID: 21752153
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Reliability of histological malignancy grade, ER and HER2 status on core needle biopsy vs surgical specimen in breast cancer.
    Munch-Petersen HD; Rasmussen BB; Balslev E
    APMIS; 2014 Sep; 122(9):750-4. PubMed ID: 24372587
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Triple-negative breast cancer: correlation between imaging and pathological findings.
    Ko ES; Lee BH; Kim HA; Noh WC; Kim MS; Lee SA
    Eur Radiol; 2010 May; 20(5):1111-7. PubMed ID: 19898850
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Organized screening detects breast cancer at earlier stage regardless of molecular phenotype.
    Holloway CMB; Jiang L; Whitehead M; Racz JM; Groome PA
    J Cancer Res Clin Oncol; 2018 Sep; 144(9):1769-1775. PubMed ID: 29909564
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Utility of estrogen receptor, progesterone receptor, and HER-2/neu analysis of multiple foci in multifocal ipsilateral invasive breast carcinoma.
    East EG; Pang JC; Kidwell KM; Jorns JM
    Am J Clin Pathol; 2015 Dec; 144(6):952-9. PubMed ID: 26573003
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Assessing the role of ultrasound in predicting the biological behavior of breast cancer.
    Irshad A; Leddy R; Pisano E; Baker N; Lewis M; Ackerman S; Campbell A
    AJR Am J Roentgenol; 2013 Feb; 200(2):284-90. PubMed ID: 23345347
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Assessment of hormonal receptor immunoexpression and Her2 status in invasive breast cancer after conservative and radical surgery.
    Ţenea-Cojan TŞ; Macovei A; Păun I; Costin AI; Georgescu CV; Georgescu CC; Vladu IM; Ene CG; Radu L
    Rom J Morphol Embryol; 2018; 59(3):763-772. PubMed ID: 30534815
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A comparison of clinical-pathological characteristics between symptomatic and interval breast cancer.
    Meshkat B; Prichard RS; Al-Hilli Z; Bass GA; Quinn C; O'Doherty A; Rothwell J; Geraghty J; Evoy D; McDermott EW
    Breast; 2015 Jun; 24(3):278-82. PubMed ID: 25771080
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Aspects in mammographic screening. Detection, prediction, recurrence and prognosis.
    Thurfjell MG
    Acta Radiol Suppl; 2001 Dec; 42(424):1-22. PubMed ID: 12040855
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Estrogen-Receptor, Progesterone-Receptor and HER2 Status Determination in Invasive Breast Cancer. Concordance between Immuno-Histochemistry and MapQuant™ Microarray Based Assay.
    Mouttet D; Laé M; Caly M; Gentien D; Carpentier S; Peyro-Saint-Paul H; Vincent-Salomon A; Rouzier R; Sigal-Zafrani B; Sastre-Garau X; Reyal F
    PLoS One; 2016; 11(2):e0146474. PubMed ID: 26829108
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Invasive cancers detected after breast cancer screening yielded a negative result: relationship of mammographic density to tumor prognostic factors.
    Roubidoux MA; Bailey JE; Wray LA; Helvie MA
    Radiology; 2004 Jan; 230(1):42-8. PubMed ID: 14695385
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Association between mammographic density and tumor marker-defined breast cancer subtypes: a case-control study.
    Shin J; Lee JE; Ko HY; Nguyen TL; Nam SJ; Hopper JL; Song YM
    Eur J Cancer Prev; 2018 May; 27(3):239-247. PubMed ID: 28957821
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Primary breast carcinoma: association of mammographic calcifications with osteopontin expression.
    Wang X; Chao L; Ma G; Chen L; Jin G; Hua M; Liu H; Ouyang A; Zhang X
    Radiology; 2010 Jan; 254(1):69-78. PubMed ID: 20019131
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clinicopathological Characteristics of Mucinous Breast Cancer: A Retrospective Analysis of a 10-Year Study.
    Lei L; Yu X; Chen B; Chen Z; Wang X
    PLoS One; 2016; 11(5):e0155132. PubMed ID: 27232881
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Mammographic features of calcifications in DCIS: correlation with oestrogen receptor and human epidermal growth factor receptor 2 status.
    Bae MS; Moon WK; Chang JM; Cho N; Park SY; Won JK; Jeon YK; Moon HG; Han W; Park IA
    Eur Radiol; 2013 Aug; 23(8):2072-8. PubMed ID: 23512196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.